Status:
UNKNOWN
Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema
Lead Sponsor:
Zhenzhen Liu
Conditions:
Breast Cancer-related Arm Lymphedema
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
It is estimated that there are 420,000 newly diagnosed breast cancer patients in China in 2020. With surgery, radiotherapy, chemotherapy, endocrine, targeted therapy and other treatment methods going ...
Detailed Description
It is estimated that there are 420,000 newly diagnosed breast cancer patients in China in 2020. With surgery, radiotherapy, chemotherapy, endocrine, targeted therapy and other treatment methods going ...
Eligibility Criteria
Inclusion
- Patients aged 18 to 70 years old
- Breast cancer, unilateral，Patients undergoing axillary lymph node dissection
- Patients voluntarily joined the study and signed informed consent
Exclusion
- arm swelling preoperatively, as assessed by bioimpedance spectroscopy (BIS) or Limb circumference measurement
- any condition that hindered them from wearing a compression sleeve
- Patients with upper limb dysfunction before surgery, including shoulder and elbow joint mobility disorders
- Patients with mental disorders, senile dementia, and cognitive impairments，were not able to complete a questionnaire independently
- Patients with bilateral breast cancer, recurrence, or metastasis to other organs.
Key Trial Info
Start Date :
October 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 16 2025
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT06095323
Start Date
October 16 2023
End Date
October 16 2025
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henan Cancer Hospital
Zhengzhou, Henan, China, 450008